Glycolic Acid Business of The Chemours Company
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Glycolic Acid Business of The Chemours Company - overview
Location
-, -, US
Primary Industry
Chemicals
About
Based in the US, Glycolic Acid Business of The Chemours Company operates as a chemical business division, specializing in Glycolic Acid, of The Chemours Company. In June 2023, the business division was acquired by PureTech Scientific Inc. , a portfolio company of Iron Path Capital, for USD 137 million. The business produces chemicals for the life sciences and specialty chemical industries.
The company specializes in the organic synthesis of ultra-high purity alpha hydroxy acids suitable for a range of technical and cosmetic grade applications.
Current Investors
PureTech Scientific Inc.
Primary Industry
Chemicals
Sub Industries
Commodity Chemicals, Medicinal Chemicals & Botanicals
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Glycolic Acid Business of The Chemours Company - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out | Completed | Glycolic Acid Business of The Chemours Company | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.